BCDA

BioCardia, Inc.

Insiders buying nowCIK 925741

BioCardia, Inc. insider trading

Insiders at BioCardia, Inc. have been buying its stock on the open market. The largest purchase in the last 30 days was Altman Peter (President and CEO · Director) buying $872 of BCDA, filed Sep 05, 2026. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.

Bought on the open market
$872
Sold
Insiders
1
Latest trade
Sep 03, 2026

From SEC filings · last 30 days

Recent BCDA insider transactions

  1. Altman PeterPresident and CEO · Director

    Bought 800 sh at $1.09 · Sep 03, 2026

    $872

    Filing

SEC Form 4 data, Q3 2024 to Q2 2026

BCDA insider trading by quarter

Between Jul 01, 2024 and Jun 30, 2026, 7 insiders traded BCDA on the open market: 59 purchases worth $2M and 1 sale worth $6.5K. In the last four quarters alone: 26 purchases ($1.1M) and 0 sales, by 3 insiders.

QuarterBoughtSold
Q2 2026+$128.7K12 buys
Q1 2026+$8K5 buys
Q4 2025+$1.4K2 buys
Q3 2025+$923.2K7 buys
Q2 2025+$802.1K22 buys
Q1 2025+$94.8K7 buys
Q4 2024+$5.1K3 buys$6.5K1 sale
Q3 2024+$9151 buy
Largest purchase
+$498K of BCDA by Stertzer Simon H (Director) on Sep 19, 2025.
Largest sale
$6.5K of BCDA by Gillis Edward M (Senior Vice President, Devices) on Dec 20, 2024.

Open-market transactions through Jun 30, 2026most recent first

  • Stertzer Simon H

    Director

    +$39K

    Jun 23, 2026

    39,000 sh · $1.00

  • Stertzer Simon H

    Director

    +$64.6K

    Jun 22, 2026

    70,200 sh · $0.92

  • Altman Peter

    President and CEO · Director

    +$768

    Jun 18, 2026

    800 sh · $0.96

  • Altman Peter

    President and CEO · Director

    +$1.3K

    Jun 17, 2026

    1,500 sh · $0.85

  • Altman Peter

    President and CEO · Director

    +$4.3K

    Jun 09, 2026

    5,000 sh · $0.85

  • Altman Peter

    President and CEO · Director

    +$1.4K

    May 20, 2026

    1,500 sh · $0.92

  • Altman Peter

    President and CEO · Director

    +$190

    May 19, 2026

    200 sh · $0.95

  • Altman Peter

    President and CEO · Director

    +$5.2K

    May 18, 2026

    5,700 sh · $0.92

  • Altman Peter

    President and CEO · Director

    +$5.2K

    May 15, 2026

    5,100 sh · $1.02

  • Altman Peter

    President and CEO · Director

    +$5.6K

    Apr 29, 2026

    5,000 sh · $1.11

  • Altman Peter

    President and CEO · Director

    +$492

    Apr 21, 2026

    400 sh · $1.23

  • Altman Peter

    President and CEO · Director

    +$738

    Apr 20, 2026

    600 sh · $1.23

  • Altman Peter

    President and CEO · Director

    +$366

    Mar 25, 2026

    300 sh · $1.22

  • Altman Peter

    President and CEO · Director

    +$744

    Mar 24, 2026

    600 sh · $1.24

  • Altman Peter

    President and CEO · Director

    +$5.7K

    Feb 04, 2026

    5,000 sh · $1.13

From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.

Don't check BCDA — let it ping you

Watch every insider filing the minute it clears the SEC

The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.

BioCardia, Inc. is outside the ~660 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.

Other companies insiders are buying now

Questions

Are BCDA insiders buying or selling?
Between Sep 03, 2026 and Sep 03, 2026, 1 BioCardia, Inc. insider made 1 open-market purchase worth $872 and no sales, a net purchase of $872.
How much BCDA stock have insiders bought and sold in the last two years?
Between Jul 01, 2024 and Jun 30, 2026, 7 BioCardia, Inc. insiders made 59 open-market purchases worth $2M and 1 sale worth $6.5K. In the four quarters to Jun 30, 2026: 26 purchases ($1.1M) and no sales. The largest purchase was Stertzer Simon H buying $498K on Sep 19, 2025. The largest sale was Gillis Edward M selling $6.5K on Dec 20, 2024.
What was the largest recent BCDA insider trade?
Altman Peter (President and CEO · Director) bought $872 of BCDA stock on Sep 03, 2026 at about $1.09 a share.
When did an insider last buy BCDA shares?
The most recent open-market purchase on file is Altman Peter (President and CEO · Director) buying $872 on Sep 03, 2026.
Where does BCDA insider trading data come from?
From the Form 4 filings BioCardia, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.

Get the free Insider Brief

The week's real signals — open-market insider buys, cluster formations and what insiders did in BCDA and across the market — in plain English, with grants and routine vesting stripped out. Free, and honest about what the data can and cannot say.

Sign up free